Newsgather

telemedicine

Sabit8 haber4 kaynakSon güncelleme: 11.06.2026

Son Haberler

Danco Appeals to Supreme Court Over Mifepristone In-Person Requirement
Acil
Siyaset·02.05.2026AI özeti

Danco Appeals to Supreme Court Over Mifepristone In-Person Requirement

Danco Laboratories filed an emergency appeal to the US Supreme Court on May 2 asking it to halt a lower court ruling requiring in-person exams before mifepristone can be prescribed. The appeal came hours after the 5th Circuit Court of Appeals temporarily reinstated the in-person dispensing requirement, blocking telemedicine providers from prescribing the abortion pill by mail in response to Louisiana's challenge. Danco warned the ruling would cause chaos and force providers and patients to guess at what is allowed. Louisiana argues mail delivery allows women to bypass abortion bans. The FDA is currently reviewing the drug's safety.

G
Guardian Business